Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

LabioTech

September 28, 2017

Study Results Confirm that Abivax’s HIV Cure Gets Rid of Virus

Labiotech

September 28, 2017

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Pharmaphorum

September 28, 2017

Abivax claims progress towards HIV cure

BioCentury

May 12, 2017

Stepwise to a cure

European Biotechnology

May 5, 2017

Abivax’ shares jump on new Phase IIa HIV data

  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn